In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Dr. Vaia Florou
Advertisement
Articles by Dr. Vaia Florou
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer
3
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
4
Beyond Pinktober: What Breast Cancer Awareness Means With Metastatic Breast Cancer
5